Growth hormone axis
PEG-MGF
Also called Pegylated MGF
per administration
Only animal or lab studies exist — no human study has set an amount.
Quick start
PEG-MGF at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 100–200 mcg per administration
- How often
- 2x per week
- Where
- Commonly subcutaneous Sites and rotation
- Time to steady level
- ~10.0 days — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for PEG-MGF describe 100–200 mcg per administration. Descriptive only, not a recommendation.
Pegylation is said to stretch it to days, but human pharmacokinetics are not established.
A pegylated form of the IGF-1Ec peptide; evidence is preclinical and the injected figures are community-derived, so no schedule table is shown.
Modelled level — 2x per week
1× is the peak after a single dose.
- Steady-state peak
- 1.48× single dose
- Time to steady state
- 10.0days
- Administrations
- 2/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Pegylated mechano growth factor literatureA pegylated form of the IGF-1Ec peptide; all figures are community-derived, with no human dosing trial.